The New Drug Rep Is an LLM: How Pharma Can Monitor AI Mentions, Brand Share, and Safety Risks Before Regulators Do
A physician in Phoenix opens ChatGPT and types: “What’s the best GLP-1 for weight loss in a patient with type […]
General
When AI Gives Off-Label Drug Advice: What Pharma Must Track Now
A patient asks ChatGPT whether their antidepressant can help with chronic pain. Another asks Gemini if a GLP-1 drug will
ChatGPT Drug Recommendations Are a Hidden Compliance Bomb — Here’s How to Defuse Them
A patient asks ChatGPT whether they can take Eliquis with ibuprofen. The model answers confidently. The answer is wrong. No
The AI Blind Spot: What Pharma Doesn’t Know Is Hurting Its Drugs
A patient with newly diagnosed Type 2 diabetes asks ChatGPT which medication her doctor is most likely to prescribe. The
How Pharma Teams Monitor AI Drug Mentions Before They Become Regulatory Problems
When a patient asks ChatGPT whether they can take Ozempic with metformin, the answer they get is not pulled from
Turn AI Monitoring Into a Team Sport: The Pharma Playbook for Tracking Drug Mentions Across ChatGPT, Gemini, and Claude
When a patient asks ChatGPT whether they can take semaglutide with metformin and gets a confident, partially wrong answer, four
How Pharma Teams Turn AI Drug Mentions Into Strategic Intelligence
Every day, millions of patients type questions about their prescriptions into ChatGPT, Gemini, Claude, and Perplexity. They ask whether Ozempic
What Patients Ask AI About Drugs That They Never Ask Doctors
There’s a question a patient on Ozempic typed into ChatGPT last year that she hadn’t mentioned to her endocrinologist in
Detect AI Drug Misinformation Before It Hits Patients: A Pharma Playbook
At some point in the last eighteen months, the drug information environment crossed a threshold. Patients stopped asking Google first.
AI Monitoring for Medical Affairs: What to Track Before the FDA Does
When a patient asks ChatGPT whether they can take Ozempic while on metformin, that answer — accurate or not —
AI Search Is Rewriting the Patient Journey — And Most Pharma Teams Haven’t Noticed
For two decades, pharmaceutical commercial teams built their patient journey models around a predictable sequence: symptom onset, physician visit, diagnosis,
When AI Prescribes Trouble: The Legal Ambiguity Pharma Can’t Ignore
ChatGPT, Gemini, and Claude are answering drug questions millions of times a day. Some of those answers are wrong. Here
